EPAS1 and breast neoplasm: Based on our own work in immunocompetent orthotopic PyMT breast tumor-bearing mice, we wonder if these seemingly oncogenic HIF-2α driven effects in tumor cells can be overcome by the tumor suppressive effects seen in myeloid HIF-2α [9].